\-\ Texto\\:\\ \ \(0\)\
\-\ enlarged\\,\\ nontender\\ right\\ testicle\\.\ \(0\)\
\-\ treatment\\ is\\ radical\\ orchiectomy\\.\\ \\ chemotherapy\\ for\\ patients\\ with\\ stage\\ 2\\ or\\ above\\ or\\ stage\\ 1\\ who\\ are\\ considered\\ high\\ risk\\ for\\ recurrence\\.\\ \ \(0\)\
\-\ http\\:\\/\\/www\\.cancer\\.gov\\/cancertopics\\/pdq\\/treatment\\/testicular\\/healthprofessional\ \(1\)\
\-\ ultrasound\\ of\\ the\\ testicles\\ demonstrated\\ a\\ large\\,\\ heterogeneous\\ hypoechoic\\ right\\ intratesticular\\ mass\\.\\ \\ multiple\\ small\\ hyperechoic\\ foci\\ consistent\\ with\\ calcifications\\ were\\ present\\ as\\ well\\ as\\ vascularity\\ within\\ the\\ mass\\.\ \(0\)\
\-\ mixed\\ germ\\ cell\\ testicular\\ tumor\ \(0\)\
\-\ testicular\\ neoplasm\ \(15\)\
\-\ abscess\ \(594\)\
\-\ hematoma\ \(500\)\
\-\ 22\\ y\\/o\\ male\\ noticed\\ \\"lumpy\\"\\,\\ painless\\ right\\ testicle\\ after\\ learning\\ to\\ perform\\ self\\ testicular\\ exam\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ testicular\\:\\ 0\\.464894946107961\ \(0\)\
\-\ testicle\\:\\ 0\\.24932221206743788\ \(0\)\
\-\ stage\\:\\ 0\\.1973792810045433\ \(0\)\
\-\ lumpy\\:\\ 0\\.18937838234167317\ \(0\)\
\-\ learning\\:\\ 0\\.16806982490226308\ \(0\)\
\-\ intratesticular\\:\\ 0\\.15301117278154563\ \(0\)\
\-\ testicles\\:\\ 0\\.1481633695927515\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.1416435844961886\ \(0\)\
\-\ radical\\:\\ 0\\.1372840050612036\ \(0\)\
\-\ perform\\:\\ 0\\.12782670135892493\ \(0\)\
\-\ self\\:\\ 0\\.12740484261380805\ \(0\)\
\-\ vascularity\\:\\ 0\\.12393687087870588\ \(0\)\
\-\ right\\:\\ 0\\.12326132979282771\ \(0\)\
\-\ noticed\\:\\ 0\\.1228938685401107\ \(0\)\
\-\ treatment\\:\\ 0\\.11806653430505962\ \(0\)\
\-\ nontender\\:\\ 0\\.11672899285143819\ \(0\)\
\-\ germ\\:\\ 0\\.11572996430099235\ \(0\)\
\-\ painless\\:\\ 0\\.11477486356581523\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.11408512173808588\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.10588838844210216\ \(0\)\
\-\ mixed\\:\\ 0\\.10258384046012754\ \(0\)\
\-\ recurrence\\:\\ 0\\.10231889763097458\ \(0\)\
\-\ foci\\:\\ 0\\.1012903011375678\ \(0\)\
\-\ as\\:\\ 0\\.09957218892944956\ \(0\)\
\-\ 22\\:\\ 0\\.09760316197799024\ \(0\)\
\-\ considered\\:\\ 0\\.09656844057821726\ \(0\)\
\-\ mass\\:\\ 0\\.0946740304992704\ \(0\)\
\-\ http\\:\\ 0\\.0916198249452421\ \(0\)\
\-\ calcifications\\:\\ 0\\.09044521225247285\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.08969599860348991\ \(0\)\
\-\ above\\:\\ 0\\.08940340101246821\ \(0\)\
\-\ risk\\:\\ 0\\.08854853494561311\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08799675816926296\ \(0\)\
\-\ hematoma\\:\\ 0\\.08673986032535304\ \(0\)\
\-\ or\\:\\ 0\\.08622437483806984\ \(0\)\
\-\ neoplasm\\:\\ 0\\.08459923702697217\ \(0\)\
\-\ enlarged\\:\\ 0\\.08448306005098608\ \(0\)\
\-\ abscess\\:\\ 0\\.07957740052243994\ \(0\)\
\-\ ultrasound\\:\\ 0\\.07644081216909353\ \(0\)\
\-\ demonstrated\\:\\ 0\\.07616253700277036\ \(0\)\
\-\ for\\:\\ 0\\.07512297768699484\ \(0\)\
\-\ cell\\:\\ 0\\.07089226738385529\ \(0\)\
\-\ high\\:\\ 0\\.07043229869762134\ \(0\)\
\-\ who\\:\\ 0\\.07010107194884362\ \(0\)\
\-\ patients\\:\\ 0\\.0697160236206444\ \(0\)\
\-\ consistent\\:\\ 0\\.06719636166594187\ \(0\)\
\-\ tumor\\:\\ 0\\.06482129807508488\ \(0\)\
\-\ small\\:\\ 0\\.0639260032275316\ \(0\)\
\-\ were\\:\\ 0\\.06388107034132393\ \(0\)\
\-\ present\\:\\ 0\\.06359125018322213\ \(0\)\
\-\ exam\\:\\ 0\\.06238518989595763\ \(0\)\
\-\ large\\:\\ 0\\.062093853539331806\ \(0\)\
\-\ multiple\\:\\ 0\\.060615661128243785\ \(0\)\
\-\ after\\:\\ 0\\.06011928530782303\ \(0\)\
\-\ well\\:\\ 0\\.06000632989181987\ \(0\)\
\-\ within\\:\\ 0\\.057077207352600086\ \(0\)\
\-\ male\\:\\ 0\\.05517731186868994\ \(0\)\
\-\ the\\:\\ 0\\.049456072795563334\ \(0\)\
\-\ with\\:\\ 0\\.048533126636016215\ \(0\)\
\-\ are\\:\\ 0\\.047024868461113\ \(0\)\
\-\ is\\:\\ 0\\.033938401119025685\ \(0\)\
\-\ to\\:\\ 0\\.030981643691900658\ \(0\)\
\-\ of\\:\\ 0\\.024252072710342628\ \(0\)\
